drugset / Trial / NCT07710664
A Study of NWRD09 in Participants With Persistent HPV16 Infection in the Anal Region
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is an open-label, single-center, investigator-initiated exploratory trial evaluating NWRD09 in 10 participants with persistent HPV16 infection in the anal region.
Timeline
- Start
- 2026-07-20
- Primary completion
- 2026-12-30
- Completion
- 2027-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NWRD09 | Messenger RNA (mRNA) | — | Intramuscular |